TiO2–PEG–DOX nanoparticles improve the chemotherapeutic effects of doxorubicin in orthotopic breast tumors and minimize the DOX side effects.
A two-photon fluorescent probe, hTP-NNO2, is developed for hypoxia evaluation via NTR detection.